LTCR‑H3‑1
Advanced primary HBV‑HCC
Pre‑clinicalUpcoming
Key Facts
About Lion TCR
Pioneering mRNA‑based TCR‑T cell immunotherapy for HBV‑driven liver cancer in Asia.
View full company profileAdvanced primary HBV‑HCC
Pioneering mRNA‑based TCR‑T cell immunotherapy for HBV‑driven liver cancer in Asia.
View full company profile